Alzheimer's Disease and Frontotemporal Dementias

A Review with Particular Reference to Pin1 Protein

 

Home

Pin1 Protein

Our Research

Our TEM Research

Our Publications

Research Team

Alzheimer's Disease

Tauopathies

About this Site

Literature:   A-K ; L-Z ; subject area

Search Site by Subject Area

Disclaimer/ Feedback

Links

Compiled by: Julian Thorpe

 

Spurious Upregulation of Cell Cycle Events

Please Note: Due to time constraints, the text part of this page has not been updated for some time. However, references are added reasonably frequently.


There is much recent research interest in increased expression of cell cycle-related proteins in AD (e.g. see Husseman et al., 2000; Vincent et al., 1996 and many other references ).

Although neurons of the adult brain are normally considered to be in a ‘terminally-differentiated’ state , accumulation of mitotic phosphoepitopes - via the spurious re-expression and activation of Cdc2/cyclin B (the mitotic phase regulating kinase) and associated cell cycle-related proteins - has been shown in AD and has attracted much research interest (Arendt et al., 1998 & 2000 ; Busser et al., 1998 ; Cataldo et al., 2000; Ding et al., 2000 ; Dranovsky et al., 2001; Giovanni et al., 1999; Harris et al., 2000 ; Husseman et al., 2000; Husseman et al., 2001; Illenberger et al., 1998; Nagy et al., 2000; Vincent et al., 1996). It has been described as an ‘interrupted’ mitotic process which leads to associated cytoskeletal abnormalities (including tangle formation) and, ultimately, apoptosis (Anderson et al., 2000 ; Engidawork et al., 2001; Mattson, 2000).

The cellular signal transduction pathways initiating these cell-cycle events are triggered by the various deleterious effects of AD upon the neurons, which might, for example, include beta-amyloid protein-induced microglia (Wu et al., 2000).

Recently, data from a Drosophila tauopathy  model suggests that tau phosphorylation is upstream of cell cycle activation (Khurana et al., 2006). This would lend more support to our hypothesis that shorfalls of endogenous Pin1 would be deleterious to neuronal function, rather than the opposing view that Pin1 might instigate neurodegeneration via cyclin D1 (and thence cell cycle) activation.

Pin1's involvement in the upregulation of cell cycle events


Some Related References

N.B. Free Medical Journals online now at: http://www.freemedicaljournals.com/
(These journals include: Neurology, Neurobiology of Disease, Journal of Neurochemistry, Alzheimer's Disease Review)

Andorfer, C, Acker, CM, Kress, Y, Hof, PR, Duff, K, Davies, P (2005) Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms. JOURNAL OF NEUROSCIENCE 25: 5446-5454

Arendt, T (2000) Alzheimer's disease as a loss of differentiation control in a subset of neurons that retain immature features in the adult brain. NEUROBIOLOGY OF AGING 21: 783-796

Arendt, T (2001) Alzheimer's disease as a disorder of mechanisms underlying structural brain self-organization. NEUROSCIENCE 102: 723-765

Arendt, T (2002)
Dysregulation of neuronal differentiation and cell cycle control in Alzheimer's disease
JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT 62: 77-85

Arendt, T (2003) Synaptic plasticity and cell cycle activation in neurons are alternative effector pathways: the 'Dr. Jekyll and Mr. Hyde concept' of Alzheimer's disease or the yin and yang of neuroplasticity. PROGRESS IN NEUROBIOLOGY 71: 83-248

Arendt, T (2004) Neurodegeneration and plasticity. INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE 22: 507-514

Arendt, T, Holzer, M and Bruckner, MK (1998) Neuronal expression of cell-cycle-markers in Alzheimer's disease. EUROPEAN JOURNAL OF NEUROSCIENCE 10: 3217

Arendt, T, Holzer, M and Gartner, U (1998) Neuronal expression of cycline dependent kinase inhibitors of the INK4 family in Alzheimer's disease. JOURNAL OF NEURAL TRANSMISSION 105: 949-960

Arendt, T, Holzer, M, Gartner, U and Bruckner, MK (1998) Aberrancies in signal transduction and cell cycle related events in Alzheimer's disease. JOURNAL OF NEURAL TRANSMISSION SU54: 147-158

Arendt, T, Holzer, M, Stobe, A, Gartner, U, Luth, HJ, Bruckner, MK, Ueberham, U (2000) Activated mitogenic signaling induces a process of dedifferentiation in Alzheimer's disease that eventually results in cell death. MOLECULAR BASIS OF DEMENTIA. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES 920: 249-255

Arendt, T, Holzer, M, Stobe, A, Ueberham, U, Gartner, U and Bruckner, MK (2000) Cell cycle regulatory factors in Alzheimer's disease. BRAIN PATHOLOGY 10: 796

Bulavin, DV, Kovalsky, O, Hollander, MC, Fornace, AJ (2003) Loss of oncogenic H-ras-induced cell cycle arrest and p38 mitogen-activated protein kinase activation by disruption of gadd45a. MOLECULAR AND CELLULAR BIOLOGY 23: 3859-3871

Busser, J, Geldmacher, DS and Herrup, K (1998) Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer's disease brain. JOURNAL OF NEUROSCIENCE 18: 2801-280

Campaner S, Kaldis P, Izraeli S, Kirsch IR (2005) Sil phosphorylation in a Pin1 binding domain affects the duration of the spindle checkpoint. Molecular and Cellular Biology 25: 6660-6672

Caricasole, A, Copani, A, Caruso, A, Caraci, F, Iacovelli, L, Sortino, MA, Terstappen, GC, Nicoletti, F (2003) The Wnt pathway, cell-cycle activation and beta-amyloid: novel therapeutic strategies in Alzheimer's disease?. TRENDS IN PHARMACOLOGICAL SCIENCES 24: 233-238  

Chen, YZ, Liu, WY, McPhie, DL, Hassinger, L, Neve, RL (2003) APP-BP1 mediates APP-induced apoptosis and DNA synthesis and is increased in Alzheimer's disease brain. JOURNAL OF CELL BIOLOGY 163: 27-33

Chen, YZ, McPhie, DL, Hirschberg, J and Neve, RL (2000) The amyloid precursor protein-binding protein APP-BP1 drives the cell cycle through the S-M checkpoint and causes apoptosis in neurons. JOURNAL OF BIOLOGICAL CHEMISTRY 275: 8929-8935

Copani, A, Condorelli, F, Caruso, A, Vancheri, C, Sala, A, Stella, AMG, Canonico, PL, Nicoletti, F and Sortino, MA (1999) Mitotic signaling by beta-amyloid causes neuronal death. FASEB JOURNAL 13: 2225-2234

Copani, A, Melchiorri, D, Caricasole, A, Martini, F, Sale, P, Carnevale, R, Gradini, R, Sortino, MA, Lenti, L, De Maria, R, Nicoletti, F (2002) beta-amyloid-induced synthesis of the ganglioside Gd3 is a requisite for cell cycle reactivation and apoptosis in neurons. JOURNAL OF NEUROSCIENCE 22: 3963-3968

Copani, A, Sortino, MA, Nicoletti, F, Stella, AMG (2002) Alzheimer's disease research enters a "new cycle": How significant? NEUROCHEMICAL RESEARCH 27: 173-176

Crenshaw DG, Yang J, Means AR, Kornbluth S (1998) The mitotic peptidyl-prolyl isomerase, Pin1, interacts with Cdc25 and Plx1. EMBO J 17:1315-1327

Delobel, P, Flament, S, Hamdane, M, Mailliot, C, Sambo, AV, Begard, S, Sergeant, N, Delacourte, A, Vilain, JP, Buee, L (2002) Abnormal Tau phosphorylation of the Alzheimer-type also occurs during mitosis . JOURNAL OF NEUROCHEMISTRY 83: 412-420

Ding, XL, Husseman, J, Tomashevski, A, Nochlin, D, Jin, LW and Vincent, I (2000) The cell cycle Cdc25A tyrosine phosphatase is activated in degenerating postmitotic neurons in Alzheimer's disease. AMERICAN JOURNAL OF PATHOLOGY 157: 1983-1990

Dranovsky, A, Vincent, I, Gregori, L, Schwarzman, A, Colflesh, D, Enghild, J, Strittmatter, W, Davies, P and Goldgaber, D (2001) Cdc2 phosphorylation of nucleolin demarcates mitotic stages and Alzheimer's disease pathology. NEUROBIOLOGY OF AGING 22: 517-528

Faltraco, F, Teipel, SJ, Blennow, K, Moller, HJ, Hampel, H (2003) A new polymorphism in the cell division cycle 2 gene is associated with Alzheimer's disease and frontotemporal dementia. PHARMACOPSYCHIATRY 36: 72

Ferrer, I, Blanco, R, Carmona, M, Puig, B (2001) Phosphorylated mitogen-activated protein kinase (MAPK/ERK-P), protein kinase of 38kDa (p38-P), stress-activated protein kinase (SAPK/JNK-P), and calcium/calmodulin-dependent kinase II (CaM kinase II) are differentially expressed in tau deposits in neurons and glial cells in tauopathies. JOURNAL OF NEURAL TRANSMISSION 108: 1397-1415

Ferrer, I, Blanco, R, Carmona, M, Puig, B, Barrachina, M, Gomez, C, Ambrosio, S (2001) Active, phosphorylation-dependent mitogen-activated protein kinase (MAPK/ERK), stress-activated protein kinase/c-Jun N-terminal kinase (SAPK/JNK), and p38 kinase expression in Parkinson's disease and Dementia with Lewy bodies. JOURNAL OF NEURAL TRANSMISSION 108: 1383-1396

Ferrer, I, Blanco, R, Carmona, M, Ribera, R, Goutan, E, Puig, B, Rey, MJ, Cardozo, A, Vinals, F and Ribalta, T (2001) Phosphorylated map kinase (ERK1, ERK2) expression is associated with early tau deposition in neurones and glial cells, but not with increased nuclear DNA vulnerability and cell death, in Alzheimer disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration. BRAIN PATHOLOGY 11: 144-158

Frasca, G, Chiechio, S, Vancher, C, Nicoletti, F, Copani, A, Sortino, MA (2004) beta-amyloid-activated cell cycle in SH-SY5Y neuroblastoma cells - Correlation with the MAP kinase pathway. JOURNAL OF MOLECULAR NEUROSCIENCE 22: 231-235

Gartner, U, Bruckner, MK, Krug, S, Schmetsdorf, S, Staufenbiel, M, Arendt, T (2003) Amyloid deposition in APP23 mice is associated with the expression of cyclins in astrocytes but not in neurons. ACTA NEUROPATHOLOGICA 106: 535-544

Giovanni, A, Wirtz-Brugger, F, Keramaris, E, Slack, R and Park, DS (1999) Involvement of cell cycle elements, cyclin-dependent kinases, pRb, and E2F center dot DP, in B-amyloid-induced neuronal death. JOURNAL OF BIOLOGICAL CHEMISTRY 274: 19011-19016

Habeck, M (2001) Is Alzheimer's disease a form of cancer? DRUG DISCOVERY TODAY 6: 651-652

Hamdane, M, Sambo, AV, Delobel, P, Begard, S, Violleau, A, Delacourte, A, Bertrand, P, Benavides, J, Buee, L (2003) Mitotic-like tau phosphorylation by p25-Cdk5 kinase complex. JOURNAL OF BIOLOGICAL CHEMISTRY 278: 34026-34034

Harris, PLR, Zhu, XW, Pamies, C, Rottkamp, CA, Ghanbari, HA, McShea, A, Feng, Y, Ferris, DK and Smith, MA (2000) Neuronal polo-like kinase in Alzheimer disease indicates cell cycle changes. NEUROBIOLOGY OF AGING 21: 837-841

Hartzler, AW, Zhu, XW, Siedlak, SL, Castellani, RJ, Avila, J, Perry, G, Smith, MA (2002) The p38 pathway is activated in Pick disease and progressive supranuclear palsy: a mechanistic link between mitogenic pathways, oxidative stress, and tau . NEUROBIOLOGY OF AGING 23: 855-859

He, JQ, Lau, AG, Yaffe, MB, Hall, RA (2001) Phosphorylation and cell cycle-dependent regulation of Na+/H+ exchanger regulatory factor-1 by Cdc2 kinase. JOURNAL OF BIOLOGICAL CHEMISTRY 276: 41559-41565

Herrup, K, Neve, R, Ackerman, SL, Copani, A (2004) Divide and die: Cell cycle events as triggers of nerve cell death. JOURNAL OF NEUROSCIENCE 24: 9232-9239

Herrup, K, Yang, Y (2001) Pictures in molecular medicine - Contemplating Alzheimer's disease as cancer: a loss of cell-cycle control. TRENDS IN MOLECULAR MEDICINE 7: 527

Husseman, JW, Nochlin, D and Vincent, I (2000) Mitotic activation: a convergent mechanism for a cohort of neurodegenerative diseases. NEUROBIOLOGY OF AGING 21: 815-828

Hutchins, JRA, Clarke, PR (2004) Many fingers on the mitotic trigger - Post-translational regulation of the Cdc25C phosphatase. CELL CYCLE 3: 41-45

Illenberger, S,  Zheng-Fischhofer, QY, Preuss, U, Stamer, K, Baumann, K, Trinczek, B, Biernat, J, Godemann, R,  Mandelkow, EM and Mandelkow, E (1998) The endogenous and cell cycle-dependent phosphorylation of tau  protein in living cells: Implications for Alzheimer's disease. MOLECULAR BIOLOGY OF THE CELL 9: 1495-1512

Janicki, SM and Monteiro, MJ (1999) Presenilin overexpression arrests cells in the G1 phase of the cell cycle - Arrest potentiated by the Alzheimer's disease PS2(N141I) mutant. AMERICAN JOURNAL OF PATHOLOGY 155: 135-144

Janicki, SM, Stabler, SM and Monteiro, MJ (2000) Familial Alzheimer's disease presenilin-1 mutants potentiate cell cycle arrest. NEUROBIOLOGY OF AGING 21: 829-836

Johansson, A, Hampel, H, Faltraco, F, Buerger, K, Minthon, L, Bogdanovic, N, Sjogren, M, Zetterberg, H, Forsell, L, Lilius, L, Wahlund, LO, Rymo, L, Prince, JA, Blennow, K (2003) Increased frequency of a new polymorphism in the cycle 2 (cdc2) gene in patients with Alzheimer's disease frontotemporal dementia. NEUROSCIENCE LETTERS 340: 69-73

Jordan-Sciutto, KL, Malaiyandi, LM, Bowser, R (2002) Altered distribution of cell cycle transcriptional regulators during Alzheimer disease. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY 61: 358-367

Katayama, H, Sasai, K, Kawai, H, Yuan, ZM, Bondaruk, J, Suzuki, F, Fujii, S, Arlinghaus, RB, Czerniak, BA, Sen, S (2004) Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53. NATURE GENETICS 36: 55-62

Kerokoski, P,  Suuronen, T,  Salminen, A,  Soininen, H and Pirttilä, T (2001) The Levels of cdk5 and p35 Proteins and Tau Phosphorylation Are Reduced during Neuronal Apoptosis. Biochem. Biophys. Res. Comm. 280: 998-1002

Khurana V, Lu Y, Steinhilb ML, Oldham S, Shulman JM, Feany MB (2006) TOR-Mediated Cell-Cycle Activation Causes Neurodegeneration in a Drosophila Tauopathy Model. Current Biology 16: 230–241

Kondratick, CM and Vandre, DD (1996) Alzheimer's disease neurofibrillary tangles contain mitosis-specific phosphoepitopes. JOURNAL OF NEUROCHEMISTRY 67: 2405-2416

Lane, HA and Nigg, EA (1997) Cell-cycle control: POLO-like kinases join the outer circle. TRENDS IN CELL BIOLOGY 7: 63-68

Lavoie, SB, Albert, AL, Vincent, M (2003) Unexpected roles of the peptidyl-prolyl cis/trans isomerase Pin1. M S-MEDECINE SCIENCES 19: 1251-1258

Lee, SS, Kim, YM, Junn, E, Lee, G, Park, KH, Tanaka, M, Ronchetti, RD, Quezado, MM, Mouradian, MM (2003) Cell cycle aberrations by alpha-synuclein over-expression and cyclin B immunoreactivity in Lewy bodies. NEUROBIOLOGY OF AGING 24: 687-696

Liu, DX and Greene, LA (2001) Neuronal apoptosis at the G1/S cell cycle checkpoint. CELL AND TISSUE RESEARCH 305: 217-228

Lu, KP (2003) Prolyl isomerase Pin1 as a molecular target for cancer diagnostics and therapeutics. CANCER CELL 4: 175-180

Mattson, MP and Klapper, W (2001) Emerging roles for telomerase in neuronal development and apoptosis. JOURNAL OF NEUROSCIENCE RESEARCH 63: 1-9

McShea, A, Wahl, AF and Smith, MA (1999) Re-entry into the cell cycle: a mechanism for neurodegeneration in Alzheimer disease. MEDICAL HYPOTHESES 52: 525-527

Milton, NGN (2002) The amyloid-beta peptide binds to cyclin B1 and increases human cyclin-dependent kinase-1 activity. NEUROSCIENCE LETTERS 322: 131-133

Mirjany, M, Ho, L, Pasinetti, GM (2002) Role of cyclooxygenase-2 in neuronal cell cycle activity and glutamate-mediated excitotoxicity. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS 301: 494-500


Miyashita, H, Mori, S, Motegi, K, Fukumoto, M, Uchida, T (2003) Pin1 is overexpressed in oral squamous cell carcinoma and its levels correlate with cyclin D1 overexpression. ONCOLOGY REPORTS 10: 455-461

Nagy, Z (2000a) Cell cycle regulation in Alzheimer's disease. EUROPEAN JOURNAL OF NEUROSCIENCE 12: 522

Nagy, Z (2000b) Cell cycle regulatory failure in neurones: causes and consequences. NEUROBIOLOGY OF AGING 21: 761-769

Nagy, Z (2003) Cell cycle-related protein expression in Alzheimer's disease and vascular disease. INTERNATIONAL PSYCHOGERIATRICS 15: 77-79

Nagy, Z, Esiri, MM and Smith, AD (1998) The cell division cycle and the pathophysiology of Alzheimer's disease. NEUROSCIENCE 87: 731-739

Nakashima, M, Meirmanov, S, Naruke, Y, Kondo, H, Saenko, V, Rogounovitch, T, Shimizu-Yoshida, Y, Takamura, N, Namba, H, Ito, M, Abrosimov, A, Lushnikov, E, Roumiantsev, P, Tsyb, A, Yamashita, S, Sekine, I (2004) Cyclin D1 overexpression in thyroid tumours from a radio-contaminated area and its correlation with Pin1 and aberrant beta-catenin expression. JOURNAL OF PATHOLOGY 202: 446-455

Nguyen, MD, Mushynski, WE, Julien, JP (2002) Cycling at the interface between neurodevelopment and neurodegeneration . CELL DEATH AND DIFFERENTIATION 9: 1294-1306

Nuydens, R, de Jong, M, Van Den Kieboom, G, Heers, C, Dispersyn, G, Cornelissen, F, Nuyens, R, Borgers, M and Geerts, H (1998) Okadaic acid-induced apoptosis in neuronal cells: Evidence for an abortive mitotic attempt. JOURNAL OF NEUROCHEMISTRY 70: 1124-1133

Ogawa, O, Lee, H, Zhu, XW, Raina, A, Harris, PLR, Castellani, RJ, Perry, G, Smith, MA (2003) Increased p27, an essential component of cell cycle control, in Alzheimer's disease. AGING CELL 2: 105-110

Ogawa, O, Zhu, XW, Lee, HG, Raina, A, Obrenovich, ME, Bowser, R, Ghanbari, HA, Castellani, RJ, Perry, G, Smith, MA (2003) Ectopic localization of phosphorylated histone H3 in Alzheimer's disease: a mitotic catastrophe? ACTA NEUROPATHOLOGICA 105: 524-528

Pei, JJ, Braak, H, Gong, CX, Grundke-Iqbal, I, Iqbal, K, Winblad, B, Cowburn, RF (2002) Up-regulation of cell division cycle (cdc) 2 kinase in neurons with early stage Alzheimer's disease neurofibrillary degeneration . ACTA NEUROPATHOLOGICA 104: 369-376

Potter, H, Geller, LN, Thomas, A and Conforto, D (2000) Cell cycle and chromosome segregation defects in Alzheimer's disease. MOLECULAR BIOLOGY OF THE CELL 11: 2945

Proteau, A, Blier, S, Albert, AL, Lavoie, SB, Traish, AM, Vincent, M (2005) The multifunctional nuclear protein p54(nrb) is multiphosphorylated in mitosis and interacts with the mitotic regulator Pin1. JOURNAL OF MOLECULAR BIOLOGY 346: 1163-1172

Raina, AK, Hochman, A, Zhu, XW, Rottkamp, CA, Nunomura, A, Siedlak, SL, Boux, H, Castellani, RJ, Perry, G and Smith, MA (2001) Abortive apoptosis in Alzheimer's disease. ACTA NEUROPATHOLOGICA 101: 305-310

Raina, AK, Monteiro, MJ, McShea, A, Smith, MA (1999) The role of cell cycle-mediated events in Alzheimer's disease. INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY 80: 71-76

Raina, AK, Zhu, XW, Rottkamp, CA, Monteiro, M, Takeda, A and Smith, MA (2000) Cyclin' toward dementia: Cell cycle abnormalities and abortive oncogenesis in Alzheimer disease. JOURNAL OF NEUROSCIENCE RESEARCH 61: 128-133

Raina, AK, Zhu, XW, Smith, MA (2004) Alzheimer's disease and the cell cycle. ACTA NEUROBIOLOGIAE EXPERIMENTALIS 64: 107-112

Rosner, M, Kowalska, A, Freilinger, A, Prusa, AR, Marton, E, Hengstschlager, M (2003) Cell cycle and cell size regulation in Down Syndrome cells. JOURNAL OF NEURAL TRANSMISSION-SUPPLEMENT 67: 51-58

Ryo, A, Liou, YC, Lu, KP, Wulf, G (2003) Prolyl isomerase Pin1: a catalyst for oncogenesis and a potential therapeutic target in cancer. JOURNAL OF CELL SCIENCE 116: 773-783

Smith, MZ, Esiri, MM, King, E and Nagy, Z (2000) The effects of cell cycle progression and Alzheimer-type pathology on cognitive decline. BRAIN PATHOLOGY 10: 788

Smith, MZ, Nagy, Z and Esiri, MM (1999) Cell cycle-related protein expression in vascular dementia and Alzheimer's disease. NEUROSCIENCE LETTERS 271: 45-48

Swatton, JE, Sellers, LA, Faull, RLM, Holland, A, Iritani, S, Bahn, S (2004) Increased MAP kinase activity in Alzheimer's and Down syndrome but not in schizophrenia human brain. EUROPEAN JOURNAL OF NEUROSCIENCE 19: 2711-2719

Thorpe JR, Mosaheb S, Hashemzadeh-Bonehi L, Cairns NJ, Kay KE, Morley SJ, Rulten S  (2004) Shortfalls in the Peptidyl-Prolyl Cis-Trans Isomerase Protein Pin1 in Neurons are Associated With Frontotemporal Dementias. Neurobiology of Disease 17: 237-249

Tsujioka, Y, Takahashi, M, Tsuboi, Y, Yamamoto, T and Yamada, T (1999) Localization and expression of cdc2 and cdk4 in Alzheimer brain tissue. DEMENTIA AND GERIATRIC COGNITIVE DISORDERS 10: 192-198

Uchida, T, Takamiya, M, Takahashi, M, Miyashita, H, Ikeda, H, Terada, T, Matsuo, Y, Shirouzu, M, Yokoyama, S, Fujimori, F, Hunter, T (2003) Pin1 and Par14 peptidyl prolyl isomerase inhibitors block cell proliferation. CHEMISTRY & BIOLOGY 10: 15-24  

Vargas, DA, Takahashi, S, Ronai, Z (2003) Mdm2: A regulator of cell growth and death. ADVANCES IN CANCER RESEARCH 89: 1-34

Vincent, I, Bu, B, Hudson, K, Husseman, J, Nochlin, D, Jin, LW (2001) Constitutive Cdc25B tyrosine phosphatase activity in adult brain neurons with M phase-type alterations in Alzheimer's disease. NEUROSCIENCE 105: 639-650

Vincent, I, Rosado, M, Davies, P (1996) Mitotic mechanisms in Alzheimer's disease? JOURNAL OF CELL BIOLOGY 132: 413-425

Wen, Y, Yang, SH, Liu, R, Brun-Zinkernagel, AM, Koulen, P, Simpkins, JW (2004) Transient cerebral ischemia induces aberrant neuronal cell cycle re-entry and Alzheimer's disease-like tauopathy in female rats. JOURNAL OF BIOLOGICAL CHEMISTRY 279: 22684-22692

Wu, Q, Combs, C, Cannady, SB, Geldmacher, DS and Herrup, K (2000) Beta-amyloid activated microglia induce cell cycling and cell death in cultured cortical neurons. NEUROBIOLOGY OF AGING 21: 797-806

Xiang, ZM, Ho, L, Valdellon, J, Borchelt, D, Kelley, K, Spielman, L, Aisen, PS, Pasinetti, GM (2002) Cyclooxygenase (COX)-2 and cell cycle activity in a transgenic mouse model of Alzheimer's Disease neuropathology. NEUROBIOLOGY OF AGING 23: 327-334

Xu, YX, Manley, JL (2004) Pinning down transcription - Regulation of RNA polymerase II activity during the cell cycle. CELL CYCLE 3: 432-435

Yang, Y, Geldmacher, DS and Herrup, K (2001) DNA replication precedes neuronal cell death in Alzheimer's disease. JOURNAL OF NEUROSCIENCE 21: 2661-2668

Yang, Y, Mufson, EJ, Herrup, K (2003) Neuronal cell death is preceded by cell cycle events at all stages of Alzheimer's disease. JOURNAL OF NEUROSCIENCE 23: 2557-2563

Zhou, XZ, Perrem, K, Lu, KP (2003) Role of Pin2/TRF1 in telomere maintenance and cell cycle control. JOURNAL OF CELLULAR BIOCHEMISTRY 89: 19-37  

Zhu, X, Webber, KM, Casadesus, G, Raina, AK, Lee, HG, Marlatt, M, Hartzler, A, Atwood, CS, Bowen, R, Perry, G, Smith, MA (2004) Mitotic and gender parallels in Alzheimer disease: Therapeutic opportunities. CURRENT DRUG TARGETS 5: 559-563 

Zhu, XW, McShea, A, Harris, PLR, Raina, AK, Castellani, RJ, Funk, JO, Shah, S, Atwood, C, Bowen, R, Bowser, R, Morelli, L, Perry, G, Smith, MA (2004) Elevated expression of a regulator of the G2/M phase of the cell cycle, neuronal CIP-1-associated regulator of cyclin B, in Alzheimer's disease. JOURNAL OF NEUROSCIENCE RESEARCH 75: 698-703

Zhu, XW, Raina, AK, Boux, H, Simmons, ZL, Takeda, A and Smith, MA (2000) Activation of oncogenic pathways in degenerating neurons in Alzheimer disease. INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE 18: 433-437

Zhu, XW, Rottkamp, CA, Boux, H, Takeda, A, Perry, G and Smith, MA (2000) Activation of p38 kinase links tau phosphorylation, oxidative  stress, and cell cycle-related events in Alzheimer disease. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY 59: 880-888